Evidence map›Paper›PMID 17568823›Full record

ArticleCanadian journal of gastroenterology = Journal canadien de gastroenterologie2007

Management of chronic hepatitis B: consensus guidelines.

Morris Sherman, Stephen Shafran, Kelly Burak, Karen Doucette, Winnie Wong, Nigel Girgrah, Eric Yoshida, Eberhard Renner, Philip Wong, Marc Deschênes

Open access · goldAbstract readConsensus Statement
In one paragraph

Article in Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.Canadian journal of gastroenterology = Journal canadien de gastroenterologie · 2012
    Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. [Analysis of clinical characteristics of 481 HBV-related liver cirrhotic patients with low viral load].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Prevention and Management of Chronic Hepatitis B.International journal of preventive medicine · 2014
    Review
  17. Observational
  18. Prevalence and correlates of HIV and hepatitis B virus coinfection in Northern Alberta.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2014
    Article
  19. Review
  20. Chronic HBV carrier's acceptance of regular surveilling program in China.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Morris ShermanDepartment of Medicine, University of Toronto, Toronto General Hospital, Toronto, Canada. morris.sherman@uhn.on.ca
Stephen Shafran
Kelly Burak
Karen Doucette
Winnie Wong
Nigel Girgrah
Eric Yoshida
Eberhard Renner
Philip Wong
Marc Deschênes
University of Alberta · CAMcGill University · CAUniversity of Toronto · CAUniversity of British Columbia · CAUniversity of Calgary · CAUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present document presents the proceedings of the consensus development conference on the management of viral hepatitis held in January 2007 under the auspices of the Canadian Association for the Study of the Liver and the Association of Medical Microbiology and Infectious Disease Canada. Several new agents have become available since the last such document was published in 2004, and new information has become available to help assess risk of adverse outcomes and who should be treated. In addition, the participants at the meeting identified a number of structural barriers that exist uniquely in Canada and that prevent physicians from properly managing their patients. The conference discussed the selection of patients for treatment and the drugs that can be used to treat these patients, as well as the treatment of hepatitis B in special populations. The present document should be read in conjunction with the companion document on the management of chronic hepatitis C.

Indexed as

Practice Guidelines as TopicAntiviral AgentsCanadaHepatitis BHumansAntiviral Agents

Identifiers

PMID17568823
PMCPMC2794455
OpenAlexW2107471334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.